Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide
CompanyDrug

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide

AnnJi Pharmaceutical Co., Ltd. (TPEx: 7754), a clinical‑stage drug development company focused on innovative small molecules, announced that it is proceeding with the U.S. portion of its pivotal Phase 3…

Asymchem's Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Asymchem’s Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Pfizer's Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Pfizer’s Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
GenFleet Therapeutics Files for Hong Kong IPO Amid KRAS Inhibitor Success
CompanyDeals

GenFleet Therapeutics Files for Hong Kong IPO Amid KRAS Inhibitor Success

Mabwell Bioscience Partners With Calico Life Sciences on 9MW3811 Development
CompanyDeals

Mabwell Bioscience Partners With Calico Life Sciences on 9MW3811 Development

Sino Biopharmaceutical's LM-108 Gains CDE BTD for Gastric Adenocarcinoma
CompanyDrug

Sino Biopharmaceutical’s LM-108 Gains CDE BTD for Gastric Adenocarcinoma

Mabwell Bioscience Grants Qilu Pharma Exclusive Rights to Mailisheng in Greater China
CompanyDeals

Mabwell Bioscience Grants Qilu Pharma Exclusive Rights to Mailisheng in Greater China

Fosun Pharma's Serplulimab Approved for ES-SCLC in the UK and India
CompanyDrug

Fosun Pharma’s Serplulimab Approved for ES-SCLC in the UK and India

Bio-Thera Solutions Initiates Phase III Trial of BAT8006 for Platinum-Resistant Ovarian Cancer
CompanyDrug

Bio-Thera Solutions Initiates Phase III Trial of BAT8006 for Platinum-Resistant Ovarian Cancer

EMA Panel Recommends Brukinsa Tablet Formulation for Approval
CompanyDrug

EMA Panel Recommends Brukinsa Tablet Formulation for Approval

CARsgen's Satri-cel NDA Accepted by China's NMPA for Gastric Adenocarcinoma
CompanyDrug

CARsgen’s Satri-cel NDA Accepted by China’s NMPA for Gastric Adenocarcinoma

Show More